Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
985 1 |
Ultima descărcare din IBN: 2016-07-10 19:13 |
SM ISO690:2012 GHINDA, Serghei, RUDIC, Valeriu, SOFRONI, Dumitru, CLIPCA, Ivana, CHIRIAC, Tatiana, ROTARU, Natalia. Acţiunea preparatului bior asupra reactivităţii imunologice la pacientele cu cancer mamar
. In: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale, 2010, nr. 4(27), pp. 152-155. ISSN 1857-0011. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale | ||||||
Numărul 4(27) / 2010 / ISSN 1857-0011 | ||||||
|
||||||
Pag. 152-155 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Studiul a inclus 19 paciente, divizate în două grupuri: а) de bază – 13 paciente, supuse chimioterapiei în combinaţie
cu preparatul BioR (în total 27 de cure de tratament) şi b) grupul martor – 6 paciente, care au fost supuse numai chimioterapiei
(în total 8 cure de tratament). Analiza reactivităţii imunologice la pacientele cu cancer mamar denotă prezenţa
dereglărilor pronunţate, atât ale indicilor imunităţii celulare, cât şi ale indicilor imunităţii umorale. La co-administrarea
preparatului BioR în cadrul chimioterapiei, la majoritatea pacientelor se determină un efect clinic pozitiv asupra indicilor
studiaţi faţă de pacientele supuse doar regimului de chimioterapie. |
||||||
|
Cerif XML Export
<?xml version='1.0' encoding='utf-8'?> <CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'> <cfResPubl> <cfResPublId>ibn-ResPubl-11218</cfResPublId> <cfResPublDate>2010-09-01</cfResPublDate> <cfVol>27</cfVol> <cfIssue>4</cfIssue> <cfStartPage>152</cfStartPage> <cfISSN>1857-0011</cfISSN> <cfURI>https://ibn.idsi.md/ro/vizualizare_articol/11218</cfURI> <cfTitle cfLangCode='RO' cfTrans='o'>Acţiunea preparatului bior asupra reactivităţii imunologice la pacientele cu cancer mamar </cfTitle> <cfAbstr cfLangCode='RO' cfTrans='o'>Studiul a inclus 19 paciente, divizate în două grupuri: а) de bază – 13 paciente, supuse chimioterapiei în combinaţie cu preparatul BioR (în total 27 de cure de tratament) şi b) grupul martor – 6 paciente, care au fost supuse numai chimioterapiei (în total 8 cure de tratament). Analiza reactivităţii imunologice la pacientele cu cancer mamar denotă prezenţa dereglărilor pronunţate, atât ale indicilor imunităţii celulare, cât şi ale indicilor imunităţii umorale. La co-administrarea preparatului BioR în cadrul chimioterapiei, la majoritatea pacientelor se determină un efect clinic pozitiv asupra indicilor studiaţi faţă de pacientele supuse doar regimului de chimioterapie.</cfAbstr> <cfAbstr cfLangCode='EN' cfTrans='o'>The study was based on 19 patients divided into two groups: а) basic - 13 patients subjected to chemotherapy in combination with BioR (total of 27 treatment courses) and b) control group - 6 patients who have undergone chemotherapy only (total 8 courses of treatment). Analysis of immunological reactivity of patients with breast cancer indicates the presence of pronounced disturbances, both of cellular immunity of humoral immunity indices. When BioR was administered in conjunction with chemotherapy, a positive clinical effect on the indices was observed, in comparison to the patients who only took chemotherapy.</cfAbstr> <cfResPubl_Class> <cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId> <cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfResPubl_Class> <cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId> <cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfResPubl_Class> <cfPers_ResPubl> <cfPersId>ibn-person-11720</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-244</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-170</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-14202</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-1193</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfPers_ResPubl> <cfPers_ResPubl> <cfPersId>ibn-person-12579</cfPersId> <cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId> <cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> </cfPers_ResPubl> </cfResPubl> <cfPers> <cfPersId>ibn-Pers-11720</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-11720-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> <cfFamilyNames>Гинда</cfFamilyNames> <cfFirstNames>Сергей</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-244</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-244-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> <cfFamilyNames>Rudik</cfFamilyNames> <cfFirstNames>V.</cfFirstNames> <cfFamilyNames>Рудик</cfFamilyNames> <cfFirstNames>Валерий</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-170</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-170-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> <cfFamilyNames>Софрони</cfFamilyNames> <cfFirstNames>Думитру</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-14202</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-14202-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> <cfFamilyNames>Clipca</cfFamilyNames> <cfFirstNames>Ivana</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-1193</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-1193-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> <cfFamilyNames>Кирияк</cfFamilyNames> <cfFirstNames>Татьяна</cfFirstNames> </cfPersName_Pers> </cfPers> <cfPers> <cfPersId>ibn-Pers-12579</cfPersId> <cfPersName_Pers> <cfPersNameId>ibn-PersName-12579-2</cfPersNameId> <cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId> <cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId> <cfStartDate>2010-09-01T24:00:00</cfStartDate> <cfFamilyNames>Ротару</cfFamilyNames> <cfFirstNames>Н.</cfFirstNames> </cfPersName_Pers> </cfPers> </CERIF>